Paul Tudor Jones Amicus Therapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

$29 Billion
Q1 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 71,291 shares of FOLD stock, worth $431,310. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,291

Previous 148,868 52.11%

Holding current value

$431,310

Previous $1.4 Million 58.56%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$8.16 - $9.85 $633,028 - $764,133	-77,577 Reduced 52.11%	71,291 $581,000
Q4 2024 Feb 14, 2025	BUY	$9.36 - $12.01 $4,811 - $6,173	514 Added 0.35%	148,868 $1.4 Million
Q3 2024 Nov 14, 2024	BUY	$9.55 - $12.09 $1.42 Million - $1.79 Million	148,354 New	148,354 $1.58 Million
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $863,199 - $1.07 Million	79,120 Added 144.97%	133,697 $1.48 Million
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $539,766 - $693,127	54,577 New	54,577 $666,000
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $123,525 - $156,482	-12,579 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $109,940 - $148,935	12,579 New	12,579 $120,000
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $551,273 - $678,490	-63,292 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $157,780 - $409,199	17,150 Added 37.17%	63,292 $625,000
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $411,454 - $760,289	30,546 Added 195.86%	46,142 $1.07 Million
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $201,032 - $247,820	15,596 New	15,596 $220,000
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $325,904 - $548,580	-49,156 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $141,005 - $202,648	18,851 Added 62.2%	49,156 $479,000
Q3 2019 Nov 14, 2019	SELL	$8.02 - $13.25 $1.5 Million - $2.48 Million	-186,971 Reduced 86.05%	30,305 $243,000
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $2.38 Million - $3.13 Million	217,276 New	217,276 $2.71 Million
Q1 2019 May 15, 2019	SELL	$10.04 - $13.92 $798,129 - $1.11 Million	-79,495 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.38 - $13.44 $359,485 - $576,549	42,898 Added 117.22%	79,495 $762,000
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $71,073 - $101,340	-6,127 Reduced 14.34%	36,597 $442,000
Q2 2018 Aug 14, 2018	BUY	$13.13 - $17.09 $560,966 - $730,153	42,724 New	42,724 $667,000

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

322M

Call Options Held

378K

Put Options Held

575K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $1.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account